Floatz logo

MERCAPTOPURINE ANHYDROUS

Burkitt's Lymphoma

Masonic Cancer Center, University of MinnesotaSmall moleculePhase 2Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Burkitt's Lymphoma cohort.

Asset / SponsorPhaseRating
VINDESINE
PETHEMA Foundation
Phase 4BBB
Alisertib
UNC Lineberger Comprehensive Cancer Center
Phase 2BB
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Nicola Goekbuget
Phase 4BB
ETOPOSIDE
Nicola Goekbuget
Phase 4BB
Equine Atg
Masonic Cancer Center, University of Minnesota
Phase 2B

View all 14 →

Same molecule, other indications

MERCAPTOPURINE ANHYDROUS is also rated in:

adult acute lymphoblastic leukemiaDormant
A
Indicative ·
81 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
A
Indicative ·
80 / 100
View asset →
childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →